Stock listing
BBNX Stock Price, News, Filings & Events — Beta Bionics, Inc.
Selected listing: BBNX · NASDAQ · USD · US
This page tracks Beta Bionics, Inc.'s BBNX:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following BBNX:NASDAQ. BBNX:NASDAQ is the stock-level entry point for investors researching Beta Bionics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Beta Bionics, Inc. is a public company traded under the ticker BBNX in the American market. The company has a market capitalization of approximately $770.5 million. Beta Bionics focuses on innovative solutions in the healthcare sector, specifically targeting advancements in diabetes management.
- Ticker
- BBNX:NASDAQ
- Asset type
- Stock
- Market cap
- $887.2M
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- NASDAQ
- Currency
- USD
Beta Bionics, Inc. BBNX:NASDAQ stock context
This page tracks Beta Bionics, Inc.'s BBNX:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following BBNX:NASDAQ. BBNX:NASDAQ is the stock-level entry point for investors researching Beta Bionics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Beta Bionics, Inc. is a public company traded under the ticker BBNX in the American market. The company has a market capitalization of approximately $770.5 million. Beta Bionics focuses on innovative solutions in the healthcare sector, specifically targeting advancements in diabetes management.
Latest news from Beta Bionics, Inc.
Beta Bionics Announces Second Quarter 2026 Financial Results and Updates Full Year 2026 Guidance
July 29, 2026
Beta Bionics First in Automated Insulin Delivery to Publish Near Real-Time Real-World Data on a Public Website
June 2, 2026
Beta Bionics Updates Commercialization Timeline Expectations for Mint™, its Patch Pump in Development
May 21, 2026
Beta Bionics Announces First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance
April 21, 2026
Beta Bionics Introduces Bionic Insights™ in Bionic Reports — Transforming How Clinicians Understand and Optimize Diabetes Care
March 31, 2026
Beta Bionics, Inc. earnings calls
Beta Bionics, Inc. (BBNX) Q2 2026 Earnings Call
July 29, 2026 · Replay with transcript and chapters
Beta Bionics, Inc. (BBNX) Q1 2026 Earnings Call
April 21, 2026 · Replay with transcript and chapters
Beta Bionics, Inc. (BBNX) Q4 2025 Earnings Call
February 17, 2026 · Replay with transcript and chapters
Beta Bionics, Inc. (BBNX) Q3 2025 Earnings Call
October 28, 2025 · Replay with transcript and chapters
Beta Bionics, Inc. (BBNX) Q2 2025 Earnings Call
July 29, 2025 · Replay with transcript and chapters
Beta Bionics, Inc. (BBNX) Q1 2025 Earnings Call
May 6, 2025 · Replay with transcript and chapters
Research Beta Bionics, Inc.
Beta Bionics, Inc. investor report
Review AI stock analysis and investor report context for BBNX:NASDAQ.
Beta Bionics, Inc. company profile
View the public company page for Beta Bionics, Inc. on 6ix.
Beta Bionics, Inc. news
Read company news and market updates connected to Beta Bionics, Inc..
Beta Bionics, Inc. investor events
Find investor webinars, events, and replay context for Beta Bionics, Inc..